Current diagnostic tumor biopsies are invasive and can disrupt and spread the tumor. Liquid biopsies are inadequate for early-stage detection, resulting in lower survival rates and poorer prognoses. Raman spectroscopy can detect many cancers by identifying subtle cancer-associated metabolites in circulating biofluids. This study investigates preanalytical variables affecting Raman biofluid measurements in head and neck cancer patients, namely spatially correlated changes caused by Marangoni and capillary flow, aiming to streamline testing by reducing sample acquisition time and human intervention. This method is fully automated, providing a high-throughput assay for large-scale screening, paving the way for widely available, sensitive cancer detection.
Access to the requested content is limited to institutions that have purchased or subscribe to SPIE eBooks.
You are receiving this notice because your organization may not have SPIE eBooks access.*
*Shibboleth/Open Athens users─please
sign in
to access your institution's subscriptions.
To obtain this item, you may purchase the complete book in print or electronic format on
SPIE.org.
INSTITUTIONAL Select your institution to access the SPIE Digital Library.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.